Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence.

Santambrogio E, Nicolosi M, Vassallo F, Castellino A, Novo M, Chiappella A, Vitolo U.

Expert Rev Hematol. 2019 Sep;12(9):787-796. doi: 10.1080/17474086.2019.1643232. Epub 2019 Aug 8.

PMID:
31305170
2.

High-grade B-cell lymphoma: how to diagnose and treat.

Novo M, Castellino A, Nicolosi M, Santambrogio E, Vassallo F, Chiappella A, Vitolo U.

Expert Rev Hematol. 2019 Jul;12(7):497-506. doi: 10.1080/17474086.2019.1624157. Epub 2019 Jun 19.

PMID:
31150587
3.

Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience.

Marangon M, Stefoni V, Castellino A, Visco C, Tani M, Cox MC, Marasca R, Tecchio C, Devizzi L, Monaco F, Romano A, Rusconi C, Rigacci L, Castellino C, Gaudio F, Argnani L, Zinzani PL.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e321-e323. doi: 10.1016/j.clml.2019.03.020. Epub 2019 Mar 29. No abstract available.

PMID:
31080169
4.

Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.

Castellino A, Pulido JS, Johnston PB, Ristow KM, Nora Bennani N, Inwards DJ, Macon WR, Micallef INM, King RL, Salomao DR, Witzig TE, Habermann TM, Nowakowski GS.

Am J Hematol. 2019 Mar;94(3):291-298. doi: 10.1002/ajh.25350. Epub 2018 Dec 5.

PMID:
30516868
5.

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

Castellino A, Chiappella A, LaPlant BR, Pederson LD, Gaidano G, Macon WR, Inghirami G, Reeder CB, Tucci A, King RL, Congiu A, Foran JM, Pavone V, Rivera CE, Spina M, Ansell SM, Cavallo F, Molinari AL, Ciccone G, Habermann TM, Witzig TE, Vitolo U, Nowakowski GS.

Blood Cancer J. 2018 Nov 8;8(11):108. doi: 10.1038/s41408-018-0145-9.

6.

Correction to: The diagnosis and treatment of primary vitreoretinal lymphoma: a review.

Pulido JS, Johnston PB, Nowakowski GS, Castellino A, Raja H.

Int J Retina Vitreous. 2018 Jun 4;4:22. doi: 10.1186/s40942-018-0126-y. eCollection 2018.

7.

The diagnosis and treatment of primary vitreoretinal lymphoma: a review.

Pulido JS, Johnston PB, Nowakowski GS, Castellino A, Raja H.

Int J Retina Vitreous. 2018 May 7;4:18. doi: 10.1186/s40942-018-0120-4. eCollection 2018. Review. Erratum in: Int J Retina Vitreous. 2018 Jun 4;4:22.

8.

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

Stefoni V, Pellegrini C, Broccoli A, Baldini L, Tani M, Cencini E, Figuera A, Ansuinelli M, Bernocco E, Cantonetti M, Cox MC, Ballerini F, Rusconi C, Visco C, Arcaini L, Fama A, Marasca R, Volpetti S, Castellino A, Califano C, Cavaliere M, Gini G, Liberati AM, Musuraca G, Lucania A, Ricciuti G, Argnani L, Zinzani PL.

Oncologist. 2018 Sep;23(9):1033-1038. doi: 10.1634/theoncologist.2017-0597. Epub 2018 Apr 19.

9.

Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.

Ciochetto C, Botto B, Passera R, Bellò M, Benevolo G, Boccomini C, Castellino A, Chiappella A, Freilone R, Nicolosi M, Orsucci L, Pecoraro C, Pregno P, Bisi G, Vitolo U.

Ann Hematol. 2018 Sep;97(9):1619-1626. doi: 10.1007/s00277-018-3328-3. Epub 2018 Apr 16.

PMID:
29663029
10.

Intensified therapy in diffuse large B-cell lymphoma.

Novo M, Castellino A, Chiappella A.

Oncotarget. 2017 Dec 29;9(16):12548-12549. doi: 10.18632/oncotarget.23770. eCollection 2018 Feb 27. No abstract available.

11.

Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with Defibrotide.

Castellino A, Guidi S, Dellacasa CM, Gozzini A, Donnini I, Nozzoli C, Manetta S, Aydin S, Giaccone L, Festuccia M, Brunello L, Maffini E, Bruno B, David E, Busca A.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018001. doi: 10.4084/MJHID.2018.001. eCollection 2018.

12.

A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma.

Ghione P, Cavallo F, Visco C, Chen Z, Castellino A, Tisi MC, Dogliotti I, Nicolosi M, Boccadoro M, Leonard JP, Vitolo U, Martin P.

Br J Haematol. 2018 Dec;183(5):828-831. doi: 10.1111/bjh.15057. Epub 2017 Dec 19. No abstract available.

13.

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.

Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U.

Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.

PMID:
28668386
14.

Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma.

Chiappella A, Santambrogio E, Castellino A, Nicolosi M, Vitolo U.

Expert Rev Hematol. 2017 Aug;10(8):697-705. doi: 10.1080/17474086.2017.1350164. Epub 2017 Jul 14. Review.

PMID:
28665232
15.

Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.

Chiappella A, Castellino A, Nicolosi M, Santambrogio E, Vitolo U.

Expert Rev Hematol. 2017 Apr;10(4):289-297. doi: 10.1080/17474086.2017.1305264. Epub 2017 Mar 27. Review.

PMID:
28290728
16.

Follicular Lymphoma: The Management of Elderly Patient.

Castellino A, Santambrogio E, Nicolosi M, Botto B, Boccomini C, Vitolo U.

Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017009. doi: 10.4084/MJHID.2017.009. eCollection 2017. Review.

17.

State-of-the-art Therapy for Advanced-stage Diffuse Large B-cell Lymphoma.

Chiappella A, Castellino A, Vitolo U.

Hematol Oncol Clin North Am. 2016 Dec;30(6):1147-1162. doi: 10.1016/j.hoc.2016.07.002. Review.

PMID:
27888872
18.

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.

Vitolo U, Chiappella A, Franceschetti S, Carella AM, Baldi I, Inghirami G, Spina M, Pavone V, Ladetto M, Liberati AM, Molinari AL, Zinzani P, Salvi F, Fattori PP, Zaccaria A, Dreyling M, Botto B, Castellino A, Congiu A, Gaudiano M, Zanni M, Ciccone G, Gaidano G, Rossi G; Fondazione Italiana Linfomi.

Lancet Oncol. 2014 Jun;15(7):730-7. doi: 10.1016/S1470-2045(14)70191-3. Epub 2014 May 13.

PMID:
24831981
19.

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.

Chiappella A, Tucci A, Castellino A, Pavone V, Baldi I, Carella AM, Orsucci L, Zanni M, Salvi F, Liberati AM, Gaidano G, Bottelli C, Rossini B, Perticone S, De Masi P, Ladetto M, Ciccone G, Palumbo A, Rossi G, Vitolo U; Fondazione Italiana Linfomi.

Haematologica. 2013 Nov;98(11):1732-8. doi: 10.3324/haematol.2013.085134. Epub 2013 Jun 28.

20.

Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells.

Aspland SE, Ballatore C, Castillo R, Desharnais J, Eustaquio T, Goelet P, Guo Z, Li Q, Nelson D, Sun C, Castellino AJ, Newman MJ.

Bioorg Med Chem Lett. 2006 Oct 1;16(19):5194-8. Epub 2006 Jul 25.

PMID:
16870428
21.

The design, synthesis, and evaluation of two universal doxorubicin-linkers: preparation of conjugates that retain topoisomerase II activity.

Sun C, Aspland SE, Ballatore C, Castillo R, Smith AB 3rd, Castellino AJ.

Bioorg Med Chem Lett. 2006 Jan 1;16(1):104-7. Epub 2005 Oct 18.

PMID:
16242325
22.

A facile route to paclitaxel C-10 carbamates.

Ballatore C, Aspland SE, Castillo R, Desharnais J, Eustaquio T, Sun C, Castellino AJ, Smith AB 3rd.

Bioorg Med Chem Lett. 2005 May 16;15(10):2477-80.

PMID:
15863300
23.

Design of a gene family screening library targeting G-protein coupled receptors.

Lamb ML, Bradley EK, Beaton G, Bondy SS, Castellino AJ, Gibbons PA, Suto MJ, Grootenhuis PD.

J Mol Graph Model. 2004 Sep;23(1):15-21.

PMID:
15331050
24.

Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.

Ugarkar BG, Castellino AJ, DaRe JS, Ramirez-Weinhouse M, Kopcho JJ, Rosengren S, Erion MD.

J Med Chem. 2003 Oct 23;46(22):4750-60.

PMID:
14561094
25.

Evaluation of outcomes in nursing students using clinical concept map care plans.

Castellino AR, Schuster PM.

Nurse Educ. 2002 Jul-Aug;27(4):149-50. No abstract available.

PMID:
12131805
26.

Evaluation of a novel shape-based computational filter for lead evolution: application to thrombin inhibitors.

Srinivasan J, Castellino A, Bradley EK, Eksterowicz JE, Grootenhuis PD, Putta S, Stanton RV.

J Med Chem. 2002 Jun 6;45(12):2494-500.

PMID:
12036357
27.

Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues.

Ugarkar BG, Castellino AJ, DaRe JM, Kopcho JJ, Wiesner JB, Schanzer JM, Erion MD.

J Med Chem. 2000 Jul 27;43(15):2894-905.

PMID:
10956197
28.
29.

Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy.

Wiesner JB, Ugarkar BG, Castellino AJ, Barankiewicz J, Dumas DP, Gruber HE, Foster AC, Erion MD.

J Pharmacol Exp Ther. 1999 Jun;289(3):1669-77.

PMID:
10336567
30.

BRE: a modulator of TNF-alpha action.

Gu C, Castellino A, Chan JY, Chao MV.

FASEB J. 1998 Sep;12(12):1101-8.

PMID:
9737713
31.

Turning on transgenics.

Bialy H, Castellino A, Dove A, Einarson M, Smith O.

Nat Biotechnol. 1998 Feb;16(2):124. No abstract available.

PMID:
9487503
32.

Lighting up pest control.

Bialy H, Castellino A, Dove A, Einarson M, Smith O.

Nat Biotechnol. 1998 Feb;16(2):124. No abstract available.

PMID:
9487502
33.

A systems perspective begins to emerge in Alzheimer's.

Castellino A.

Nat Biotechnol. 1997 Dec;15(13):1347-8. No abstract available.

PMID:
9415884
34.

When the chips are down.

Castellino AM.

Genome Res. 1997 Oct;7(10):943-6. No abstract available.

35.

trans-Dominant and non-trans-dominant mutant simian virus 40 large T antigens show distinct responses to ATP.

Castellino AM, Cantalupo P, Marks IM, Vartikar JV, Peden KW, Pipas JM.

J Virol. 1997 Oct;71(10):7549-59.

36.

Chimeric protein cytotoxic against KS tumors.

Marshall A, Castellino A.

Nat Biotechnol. 1997 Apr;15(4):304. No abstract available.

PMID:
9094112
37.

A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase.

Castellino AM, Parker GJ, Boronenkov IV, Anderson RA, Chao MV.

J Biol Chem. 1997 Feb 28;272(9):5861-70.

38.

Trans-signaling by cytokine and growth factor receptors.

Castellino AM, Chao MV.

Cytokine Growth Factor Rev. 1996 Dec;7(4):297-302. Review.

PMID:
9023053
39.

[Variations in microalbuminuria in essential hypertension treated with ACE inhibitors, calcium antagonists and their association].

Abate D, CafĂ  R, Castellino AR, Maligno C, Sorrusca F, Abate FC.

Minerva Cardioangiol. 1995 Jul-Aug;43(7-8):303-7. Italian.

PMID:
8538903
40.

Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.

Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA.

Science. 1994 Sep 9;265(5178):1596-9.

PMID:
8079174
41.

[Complications of the axillo-femoral by-pass].

Agresti A, Castellino A, Petronella P, Piazza P, Russo F, De Longis G.

Minerva Chir. 1980 Dec 15-31;35(23-24):1969-76. Italian. No abstract available.

PMID:
7290410
42.

Isolation of a streptokinase cofactor from rabbit plasma.

Violand B, Castellino A, Castellino FJ.

Thromb Res. 1980 Aug 15-Sep 1;19(4-5):705-10. No abstract available.

PMID:
7192441
43.

[Transposition of the ileum in destructive surgery of the colon].

Agresti A, Rizzo S, De Longis G, Piazza P, Castellino A.

Minerva Dietol Gastroenterol. 1980 Jul-Sep;26(3):131-4. Italian. No abstract available.

PMID:
7254573
44.

[Ample gastric resection in the treatment of stomach cancer].

Agresti A, Rizzo S, Petronella P, Piazza P, Castellino A.

Minerva Dietol Gastroenterol. 1980 Jul-Sep;26(3):129-30. Italian. No abstract available.

PMID:
7254572
45.

[Epidemiology of cancer of the stomach in our clinical experience].

Agresti A, Petronella P, Piazza P, Rizzo S, Castellino A.

Minerva Dietol Gastroenterol. 1980 Jul-Sep;26(3):139-42. Italian. No abstract available.

PMID:
6789244
46.

[Growth: chances for its stimulation].

Santini R, Castellino AJ.

Rev Asoc Odontol Argent. 1969 May;57(5):158-60. Spanish. No abstract available.

PMID:
5264405
47.

[The crisis of orthodontics in Argentina].

Castellino AJ, Santini R.

Ortodoncia. 1967 Oct;31(62):45-7. Spanish. No abstract available.

PMID:
5254032
48.

[Functional orthopedics versus fixed apparatus].

CASTELLINO A, SANTINI R.

Rev Asoc Odontol Argent. 1955 Jul;43(7):250-6. Spanish. No abstract available.

PMID:
13280987

Supplemental Content

Loading ...
Support Center